A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

Clinical trial NCT00042653 · COMPLETED

Trial details

NCT number: NCT00042653
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism End Stage Renal Disease

Start date: 2002-05-01
Primary completion: 2003-07-01
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.